It was reported that on (b)(6) 2023, a 31mm amplatzer amulet left atrial appendage occluder was implanted with a 14f amplatzer torqvue 45x45 delivery sheath.During procedure, the patient was administered heparin.It was reported there was only one single deployment attempt.It was then reported 48 hours post-procedure, the patient presented with hypotension, nausea, rapid atrial fibrillation, and a moderate pericardial effusion.It was reported the pericardial effusion was located at the left atrial appendage and led to cardiac tamponade.A decision was made to perform a pericardiocentesis.It was reported the patient's rapid atrial fibrillation could not be stabilized with pharmacological intervention and a decision was made to perform cardioversion treatment but patient did not convert from atrial fibrillation to sinus rhythm.The patient status was reported as stable.
|
An event of atrial fibrillation, nausea, low blood pressure/hypotension, and pericardial effusion was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Reportedly, after post-procedure, the patient presented with hypotension, nausea, rapid atrial fibrillation, and a moderate pericardial effusion.It was reported the pericardial effusion was located at the left atrial appendage and led to cardiac tamponade.A decision was made to perform a pericardiocentesis.It was reported the patient's rapid atrial fibrillation could not be stabilized with pharmacological intervention and a decision was made to perform cardioversion treatment but patient did not convert from atrial fibrillation to sinus rhythm.The patient status was reported as stable.Based on the information received, the cause of the reported incident could not be conclusively determined.
|